MGMT and prostate carcinoma: Balic et al. [27] used HRM to interrogate promoter methylation of two genes (MGMT and APC), and compared results from paired FFPE and FF samples in 5 human breast cancer cell lines and 3 human prostate cancer cell lines; these results were also validated with the MethyLight qPCR assay.